National Security

  • United States
    In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries
    Play
    The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.   Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.
  • China
    China Strategy Initiative Launch Event
    Led by Senior Fellow Rush Doshi, the China Strategy Initiative will study and debate the questions that go to the heart of U.S. China strategy. It will launch several new programs that undertake fresh analysis, provide granular policy recommendations, and convene experts from around the world.  
  • RealEcon
    Supporting American Small Businesses Against Foreign Threats
    Small businesses are critical to U.S. national security. They’re also increasingly targeted by foreign cyberattacks. The federal government can do more to protect them.